Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Lung Cancer

Free Subscription Articles published in Genes Chromosomes Cancer Retrieve available abstracts of 6 articles: HTML format Text format

Single Articles

October 2018
1. WU SG, Liu YN, Yu CJ, Yang JC, et al
   Driver mutations of young lung adenocarcinoma patients with malignant pleural effusion.
   Genes Chromosomes Cancer. 2018;57:513-521.
   PubMed     Text format     Abstract available
   
   
   December 2017
2. LIU L, Liu H, Shao D, Liu Z, et al
   Development and clinical validation of a circulating tumor DNA test for the identification of clinically actionable mutations in non-small cell lung cancer.
   Genes Chromosomes Cancer. 2017 Dec 26. doi: 10.1002/gcc.22522.
   PubMed     Text format     Abstract available
   
   
   May 2017
3. GOW CH, Chang HT, Lim CK, Liu CY, et al
   Comparable clinical outcomes in patients with HER2-mutant and EGFR-mutant lung adenocarcinomas.
   Genes Chromosomes Cancer. 2017;56:373-381.
   PubMed     Text format     Abstract available
   
   
   April 2017
4. BI JH, Qiu ZW, Gazdar AF, Song K, et al
   Genome-wide copy number variation pattern analysis and a classification signature for non-small cell lung cancer.
   Genes Chromosomes Cancer. 2017 Apr 5. doi: 10.1002/gcc.22460.
   PubMed     Text format     Abstract available
   
   
   
5. YOSHIMURA K, Inoue Y, Mori K, Iwashita Y, et al
   Distinct prognostic roles and heterogeneity of TTF1 copy number and TTF1 protein expression in non-small cell lung cancer.
   Genes Chromosomes Cancer. 2017 Apr 5. doi: 10.1002/gcc.22461.
   PubMed     Text format     Abstract available
   
   
   March 2017
6. LEICHSENRING J, Volckmar AL, Magios N, Morais de Oliveira CM, et al
   Synonymous EGFR variant p.Q787Q is neither prognostic nor predictive in patients with lung adenocarcinoma.
   Genes Chromosomes Cancer. 2017;56:214-220.
   PubMed     Text format     Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: